{Reference Type}: Journal Article
{Title}: Racial Disparities in Medication Use During Pregnancy: Results from the NISAMI Cohort.
{Author}: de Castro CT;Leal LF;Ramos DO;Santana JDM;Cordeiro RC;Rivemales MDCC;de Araújo EM;da Silva CAL;Pereira M;Dos Santos DB;
{Journal}: J Multidiscip Healthc
{Volume}: 17
{Issue}: 0
{Year}: 2024
{Factor}: 2.919
{DOI}: 10.2147/JMDH.S455378
{Abstract}: <B>UNASSIGNED: </B>This study aimed to evaluate racial disparities in medication use and associated factors among pregnant women receiving prenatal care at Brazilian Unified Health System primary care health units in the northeast region.<BR><B>UNASSIGNED: </B>A total of 1058 pregnant women in the NISAMI Cohort were interviewed between June 2012 and February 2014. Medicines used during pregnancy were classified according to the Anatomical Therapeutic Chemical (ATC) classification system and ANVISA pregnancy risk categories. Prevalence ratios (crude and adjusted) and 95% confidence intervals (CIs) were estimated using Poisson regression with robust error variance. All analyses were stratified by race (Asian, black, brown/mixed, Brazilian indigenous, and white).<BR><B>UNASSIGNED: </B>Approximately 84% of the pregnant women used at least one medication, with a lower proportion among white women. The most reported medications were antianemic preparations (71.08%; 95% CI 68.27-73.72%), analgesics (21.74%; 95% CI 19.36-24.32%), and drugs for functional gastrointestinal disorders (18.81%; 95% CI 16.57-21.28%). Approximately 29% of women took potentially risky medications during pregnancy, with a higher prevalence among Asian and white women. Factors associated with medication use during pregnancy include a greater number of prenatal consultations, higher education levels, health problems, and smoking. In addition, maternal age above 25 years, smoking status, and two or more previous pregnancies were associated with potentially risky medication use during pregnancy.<BR><B>UNASSIGNED: </B>A high prevalence of medication use during pregnancy was found; however, this prevalence was lower among white women. Nonetheless, black and brown women used antianemic preparations less frequently. This finding suggests that race is a factor of inequity in prenatal care, demanding public policies to mitigate it.